Insmed (INSM) EBT (2010 - 2026)
Insmed (INSM) posted quarterly EBT of -$162.1 million for Q1 2026, up 36.6% year-over-year from -$118.7 million in Q1 2025, and up 50.42% quarter-over-quarter from -$326.9 million in Q4 2025.
Analysis
Insmed (INSM) EBT (2010 - 2026) Analysis & Trends
Insmed's EBT history runs 17 years deep, the most recent figure standing at -$162.1 million for Q1 2026.
- In Q1 2026, EBT rose 36.6% year-over-year to -$162.1 million; the TTM figure through Mar 2026 stood at -$1.2 billion (down 16.74% YoY), while the FY2025 annual figure was -$1.3 billion, down 39.74% from the prior year.
- EBT for Q1 2026 stood at -$162.1 million, up from -$326.9 million in the prior quarter.
- The five-year high for EBT was -$94.2 million in Q1 2022, with the low at -$368.7 million in Q3 2025.
- The 5-year median for EBT is -$185.1 million (2023), against an average of -$210.1 million.
- The sharpest annual moves came in 2023 and 2026: EBT sank 156.75% in 2023, then surged 36.6% in 2026.
- Insmed's EBT stood at -$160.0 million in 2022, then retreated by 15.67% to -$185.1 million in 2023, then decreased by 26.6% to -$234.3 million in 2024, then plunged by 39.55% to -$326.9 million in 2025, then soared by 50.42% to -$162.1 million in 2026.
- Business Quant data shows INSM's EBT at -$162.1 million in Q1 2026, -$326.9 million in Q4 2025, and -$368.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | 542.00 Mn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | -767.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 312.46 Mn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Incyte | 25.60 Bn | 21.07 Bn | 1.57 Bn | 751.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.37 Mn |
| Mar 31, 2026 | -162.10 Mn |
| Dec 31, 2025 | -326.93 Mn |
| Sep 30, 2025 | -368.70 Mn |
| Jun 30, 2025 | -320.44 Mn |
| Mar 31, 2025 | -255.67 Mn |
| Dec 31, 2024 | -234.28 Mn |
| Sep 30, 2024 | -219.51 Mn |
| Jun 30, 2024 | -299.77 Mn |
| Mar 31, 2024 | -156.50 Mn |
| Dec 31, 2023 | -185.06 Mn |
| Sep 30, 2023 | -158.39 Mn |
| Jun 30, 2023 | -244.28 Mn |
| Mar 31, 2023 | -159.28 Mn |
| Dec 31, 2022 | -160.00 Mn |
| Sep 30, 2022 | -130.77 Mn |
| Jun 30, 2022 | -95.14 Mn |
| Mar 31, 2022 | -94.24 Mn |
| Dec 31, 2021 | -113.02 Mn |
| Sep 30, 2021 | -115.29 Mn |